B-cell senescence-associated biomarkers

1. B-cell senescence-associated biomarkers are associated with BRAF mutation burden in silico.

   “The high-risk group exhibited distinct immune infiltration patterns, increased BRAF mutation burden”

   In silicoin high-risk group vs low-risk group in PTC

   Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma

   Translational cancer research·17 Apr 2026

More on BRAF mutation burden

1. B-cell senescence-associated biomarkers predict progression-free survival in silico.

   “stratified patients into high- (HRG) and low-risk groups (LRG) with significantly different progression-free outcomes”

   In silicoin papillary thyroid carcinoma

   Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma

   Translational cancer research·17 Apr 2026